Addiction

Clearmind Medicine’s MEAI Spotlighted in Prestigious Review: Leading Experts Affirm Transformative Potential for Alcohol Use Disorder Treatment

Vancouver, Canada, Dec. 12, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a…

1 week ago

Ritten Announces $35M Series B Investment Led by Five Elms Capital

PHILADELPHIA, Dec. 11, 2025 /PRNewswire/ -- Ritten, a leading AI-powered system of record for behavioral health providers, today announced a $35…

2 weeks ago

LIV Recovery Center Expands Family Care & Support to Address Hidden Impact of Addiction

ALPHARETTA, GEORGIA / ACCESS Newswire / December 11, 2025 / LIV Recovery Center has launched a comprehensive Family Care &…

2 weeks ago

Disrupting Healthcare’s Billion-Dollar Leak With Matt Seefeld

The U.S. healthcare revenue cycle is a multi billion-dollar problem plagued by inefficiency. MedEvolve CEO Matt Seefeld explains how generative…

3 weeks ago

Neuphoria Responds to Lynx1’s Revised Indication of Interest at a Reduced Price and Premium

Neuphoria Will Continue its Well-Planned Strategic Alternatives Review, Which has Garnered Significant Positive Interest Urges Stockholders to Vote “FOR” BOTH of…

3 weeks ago

With Its Focus on Integrated Health Care, Lowering Recidivism and Data Analytics, Armor Health expands MAT and OTP programs for Franklin County, Ohio.

COLUMBUS, Ohio, Dec. 3, 2025 /PRNewswire/ -- Armor Health (ArmorHealthcare.com) Armor Health has enhanced its Medication-Assisted Treatment (MAT) and Opioid…

3 weeks ago

President Trump’s Most Difficult Marijuana Decision: Why MMJ International Holding Is A Solution

A Geopolitical, Legal, and Public-Health Crisis-and Why MMJ International Holdings Offers a Viable Federal Solution"President Trump is facing an impossible…

3 weeks ago

RejuvaKnee Reviews: Don’t Waste Your Money Without Being Informed?

NEW YORK CITY, NY / ACCESS Newswire / December 1, 2025 / Due to yearnings of our readers for in-depth…

3 weeks ago

Neuphoria Provides Facts, Exposes False Narratives in Response to Lynx1 Fictions

BURLINGTON, Mass., Dec. 01, 2025 (GLOBE NEWSWIRE) -- Neuphoria Therapeutics Inc. (“Neuphoria” or the “Company”) (NASDAQ: NEUP), a clinical-stage biotechnology…

3 weeks ago